Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Optimal treatment strategies for high-risk acute promyelocytic leukemia

28 Jan 2016

Abstract excerpt

PURPOSE OF REVIEW: Despite major advances in the treatment of acute promyelocytic leukemia (APL), high-risk APL still poses unique challenges. The purpose of this review is to outline current evidence for evaluation and management of high-risk APL and discuss areas of ongoing and future investigation. RECENT FINDINGS: With the changing treatment paradigm in APL and increasing use of arsenic trioxide (ATO),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Arsenic contamination and mitigation
Share to Retinoids in leukemia and cellular processes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26825698
DOI: 10.1097/moh.0000000000000215

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Optimal treatment strategies for high-risk acute promyelocytic leukemiaPMID 26825698Read ↗

Treatment of Acute Promyelocytic LeukemiaSemantic proximity Read ↗

Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia.Semantic proximity Read ↗

Curative Strategies in Acute Promyelocytic LeukemiaSemantic proximity Read ↗

Optimizing the Treatment of Acute Promyelocytic Leukemia: A Maintenance-Free Strategy for Complete RemissionSemantic proximity Read ↗

Acute promyelocytic leukemia: from highly fatal to highly curableSemantic proximity Read ↗

Acute promyelocytic leukemia (APL): remaining challenges towards a cure for allSemantic proximity Read ↗

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceSemantic proximity Read ↗

Recent advances in acute promyelocytic leukaemiaSemantic proximity Read ↗

Acute Promyelocytic Leukemia: Pathophysiology, Diagnosis and Clinical ManagementSemantic proximity Read ↗

Integration of Genomic and Transcriptomic Markers Improves the Prognosis Prediction of Acute Promyelocytic LeukemiaSemantic proximity Read ↗

Acute promyelocytic leukemia (APL): a review of the literatureSemantic proximity Read ↗

Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment StrategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.